Fleroxacin
Alternative Names: AM 833; Megalocin; Megalone; Quinodis; RO 236240Latest Information Update: 12 Dec 2006
At a glance
- Originator Kyorin Pharmaceutical
- Developer Kyorin Pharmaceutical; Roche
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Bacterial infections
Most Recent Events
- 28 Nov 2001 No-Development-Reported for Bacterial infections in France (PO)
- 28 Nov 2001 No-Development-Reported for Bacterial infections in Ireland (PO)
- 28 Nov 2001 No-Development-Reported for Bacterial infections in Italy (PO)